Pain Medicine · Inverness, FL
NPI
1043205305
Since 2005
Specialty
Pain Medicine
Code 208VP0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
305 S Line Ave
Inverness, FL, 34452
Phone (352) 344-4791
Groups this clinician bills Medicare through
Medicare paid, 2024
$235K
10,022 services
Medicare patients, 2024
709
Average age 74
Drug cost, 2024
$816K
19,294 prescriptions
Company payments, 2025
$103
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Robert Ulseth was code J1010 (injection, methylprednisolone acetate, 1 mg), 5,283 times for 49 patients. In total Robert Ulseth billed 10,022 services in 48 codes, and Medicare paid $235K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 5,283 | 49 | $0.10 | $545 |
| 99231 Hospital E&M - Subsequent | Facility | 1,031 | 234 | $38.19 | $39K |
| 99213 Office E&M - Established | Office | 799 | 283 | $62.21 | $50K |
| 80305 Drug Tests | Office | 527 | 290 | $12.35 | $6,508 |
| 99232 Hospital E&M - Subsequent | Facility | 336 | 158 | $60.61 | $20K |
| 99308 SNF E&M | Facility | 285 | 93 | $56.81 | $16K |
| 99307 SNF E&M | Facility | 248 | 89 | $29.47 | $7,307 |
| 99214 Office E&M - Established | Office | 213 | 143 | $93.78 | $20K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 189 | 35 | $0.70 | $133 |
| 99222 Hospital E&M - Initial | Facility | 151 | 147 | $99.66 | $15K |
| 99348 Home E&M - New and Established | Office | 140 | 40 | $54.26 | $7,596 |
| 99441 Telephone Services | Office | 109 | 71 | $20.05 | $2,185 |
| 62323 Nerve Block Injection - Back | Office | 81 | 49 | $185.67 | $15K |
| 99347 Home E&M - New and Established | Office | 79 | 25 | $32.51 | $2,568 |
| 99442 Telephone Services | Office | 59 | 43 | $54.85 | $3,236 |
By year: 2022 $291K for 6,098 services; 2023 $260K for 5,485 services; 2024 $235K for 10,022 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 527 | 290 | $12.35 | $6,508 |
Medicare prescription drug claims, 2024
In 2024, the drug Robert Ulseth prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 3,377 prescriptions and refills. In total Robert Ulseth wrote 19,294 Medicare prescriptions that cost $816K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 3,377 | 3,377 | 516 | $104K |
| Oxycodone Hcl Generic | 3,128 | 3,128 | 482 | $63K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 2,378 | 2,378 | 313 | $83K |
| Morphine Sulfate Er Morphine Sulfate | 1,601 | 1,601 | 205 | $42K |
| Tramadol Hcl Generic | 1,032 | 1,032 | 218 | $14K |
| Methadone Hcl Generic | 833 | 833 | 122 | $13K |
| Fentanyl Generic | 824 | 824 | 104 | $59K |
| Pregabalin Generic | 495 | 672 | 80 | $21K |
| Quetiapine Fumarate Generic | 451 | 957 | 156 | $8,884 |
| Duloxetine Hcl Generic | 413 | 982 | 170 | $13K |
| Alprazolam Generic | 394 | 432 | 83 | $1,774 |
| Morphine Sulfate Generic | 361 | 361 | 55 | $11K |
| Gabapentin Generic | 329 | 747 | 106 | $8,355 |
| Tizanidine Hcl Generic | 231 | 479 | 76 | $4,410 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 211 | 211 | 50 | $5,281 |
Brand drugs: 759 claims; generic drugs: 18,535 claims; opioid claims: 14,297.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Robert Ulseth $103 ($103 in general payments such as food, travel and fees) from 4 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $53.3.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.